Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis

The Cochrane Database of Systematic Reviews
June D Cody, Elisabeth M Hodson

Abstract

Treatment with recombinant human erythropoietin (rHuEPO) in dialysis patients has been shown to be highly effective in terms of correcting anaemia and improving quality of life. There is debate concerning the benefits of rHuEPO use in predialysis patients which may accelerate the deterioration of kidney function. However the opposing view is that if rHuEPO is as effective in predialysis patients, improving the patient's sense of well-being may result in the onset of dialysis being delayed. This is an update of a review first published in 2001 and last updated in 2005. The objective of this review was to ascertain the effects of rHuEPO treatment in predialysis patients primarily in terms of the timing of the onset of dialysis; but also that predialysis rHuEPO: 1) corrects haemoglobin/haematocrit (markers of anaemia); 2) improves quality of life; and 3) is not associated with an increased incidence of adverse events such as hastening of the onset of dialysis, increased hypertension, clotting of arterio-venous fistulae or seizures. We searched the Cochrane Kidney and Transplant's Specialised Register (up to 29 June 2015) through contact with the Trials' Search Co-ordinator using search terms relevant to this review. Randomised con...Continue Reading

References

Oct 1, 1990·The American Journal of Medicine·A J WatsonJ L Spivak
Jan 1, 1990·American Journal of Nephrology·H J Ward
Jan 1, 1990·American Journal of Nephrology·P A AbrahamC E Halstenson
Dec 1, 1989·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·K S KleinmanR I Abels
Jul 20, 1989·The New England Journal of Medicine·J W EschbachJ W Adamson
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D L GarciaB M Brenner
Nov 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·F K LinZ Stabinsky
Apr 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D A RevickiR L Benz
Nov 19, 1994·BMJ : British Medical Journal·S G Thompson
Nov 1, 1994·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D RothC A Shadur
Mar 1, 1996·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A LevinM Lewis
May 23, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·K U Eckardt, UNKNOWN Cardiovascular risk Reduction by Early Anemia Treatment with Epoetin Beta (CREATE) Trial
Nov 1, 2001·The Cochrane Database of Systematic Reviews·J CodyA MacLeod
Mar 4, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Vladimír TeplanUNKNOWN Czech multicenter study
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Jul 22, 2005·The Cochrane Database of Systematic Reviews·J CodyA Macleod
Sep 14, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Iain C MacdougallJonathan T C Kwan
Nov 17, 2006·The New England Journal of Medicine·Tilman B DrüekeUNKNOWN CREATE Investigators
Nov 30, 2006·Journal of the American Society of Nephrology : JASN·Francesco LocatelliPietro Pozzoni
Oct 24, 2009·Journal of the American Society of Nephrology : JASN·Kai-Uwe EckardtTilman B Drueke
Apr 1, 2014·The Cochrane Database of Systematic Reviews·Suetonia C PalmerGiovanni F M Strippoli

❮ Previous
Next ❯

Citations

Jan 10, 2017·The Cochrane Database of Systematic Reviews·Deirdre HahnElisabeth M Hodson
Aug 26, 2017·The Cochrane Database of Systematic Reviews·Bita MesgarpourHarald Herkner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
C Jacobs
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
B BrangerJ Fourcade
© 2022 Meta ULC. All rights reserved